{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:02:31Z","timestamp":1790665351858,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To identify prognostic factors for poor visual outcomes in patients with isolated retinal vasculitis and to elucidate the outcome of immunosuppressive treatment without the use of antituberculosis drugs for patients with retinal vasculitis associated with a positive QuantiFERON-TB Gold In-Tube (QFT) test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective chart review was performed of patients presenting with retinal vasculitis. After the diagnosis of active retinal vasculitis had been confirmed by fluorescein angiography and other possible causes of retinal vasculitis had been excluded, patients were categorized into two groups by their QFT result. Potential associated factors between the poor and good visual outcome groups were statistically analyzed by the chi-square test and logistic regression model with generalized estimating equations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seventy-three eyes (48 patients) were enrolled in this study. After univariate analysis, multivariate logistic regression analysis was performed and revealed that logMAR visual acuity at the initial visit (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01) and outer retinal disruption (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03) were the two factors significantly associated with poor visual outcomes. Systemic corticosteroids were administered without the use of antituberculosis drugs to all 16 cases of presumed tuberculous retinal vasculitis associated with positive QFT (26 eyes), 10 (63%) of whom were given nonsteroidal immunosuppressive drugs and achieved inflammatory control and treatment success.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Risk factors leading to poor visual outcome in patients with isolated retinal vasculitis have been identified. Immunosuppressive treatment without antituberculosis drugs seems to be a promising regimen for selected patients with presumed tuberculous retinal vasculitis under vigilant care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003558","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T21:00:12Z","timestamp":1657141212000},"page":"1897-1908","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["ISOLATED RETINAL VASCULITIS"],"prefix":"10.1097","volume":"42","author":[{"given":"Sukhum","family":"Silpa-archa","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Withawat","family":"Sapthanakorn","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[{"name":"Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts;"},{"name":"Ocular Immunology and Uveitis Foundation, Waltham, Massachusetts; and"},{"name":"Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","article-title":"Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis","volume":"157","author":"La Distia Nora","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/bjophthalmol-2014-306474","article-title":"Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence","volume":"100","author":"Agrawal","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/09273948.2014.986584","article-title":"The role of anti-tubercular therapy in patients with presumed ocular tuberculosis","volume":"23","author":"Agrawal","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/09273948.2016.1178304","article-title":"Diagnosis of ocular tuberculosis","volume":"26","author":"Ang","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10156-009-0686-8","article-title":"Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays","volume":"15","author":"Mori","year":"2009","journal-title":"J Infect Chemother"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/09273940903168688","article-title":"Strengths and weaknesses of diagnostic tools for tuberculous uveitis","volume":"17","author":"Vasconcelos-Santos","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1378\/chest.06-2471","article-title":"Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy","volume":"131","author":"Lalvani","year":"2007","journal-title":"Chest"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s10792-017-0739-4","article-title":"Review of people with retinal vasculitis and positive QuantiFERON((R))-TB gold test in an area nonendemic for tuberculosis","volume":"38","author":"Brunner","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jamaophthalmol.2020.6985","article-title":"Tuberculosis exposure with risk of beh\u00e7et disease among patients with uveitis","volume":"139","author":"Zhong","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2147\/OPTH.S65254","article-title":"Ocular tuberculosis: current perspectives","volume":"9","author":"Shakarchi","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2021.04.024","article-title":"The association between QuantiFERON-TB Gold test and clinical manifestations of uveitis in the United States","volume":"230","author":"Yakin","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0161-6420(02)00973-9","article-title":"Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan","volume":"109","author":"Morimura","year":"2002","journal-title":"Ophthalmology"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/IAE.0000000000001239","article-title":"Peripheral retinal vasculitis: analysis of 110 consecutive cases and a contemporary reappraisal of tubercular etiology","volume":"37","author":"Agrawal","year":"2017","journal-title":"Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/IAE.0000000000001019","article-title":"Visual outcome and poor prognostic factors in isolated idiopathic retinal vasculitis","volume":"36","author":"Maleki","year":"2016","journal-title":"Retina"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/bjo.72.6.442","article-title":"A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis","volume":"72","author":"Stanford","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bjo.73.9.714","article-title":"A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features","volume":"73","author":"Graham","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/eye.1996.71","article-title":"Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis","volume":"10","author":"Palmer","year":"1996","journal-title":"Eye (Lond)"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1869-5760-4-9","article-title":"Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation","volume":"4","author":"Nazari","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2020.06.052","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ajo.2009.11.020","article-title":"Ocular signs predictive of tubercular uveitis","volume":"149","author":"Gupta","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4103\/0301-4738.198857","article-title":"Polymerase chain reaction for mycobacterium tuberculosis DNA detection from ocular fluids in patients with various types of choroiditis in a referral eye center in India","volume":"64","author":"Biswas","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/IAE.0000000000002194","article-title":"The collaborative ocular tuberculosis study (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis","volume":"39","author":"Gunasekeran","year":"2019","journal-title":"Retina"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09273948.2018.1541326","article-title":"Antituberculous treatment itself might prevent visual impairment in presumed tuberculosis-related uveitis","volume":"28","author":"Lloren\u00e7","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"e993","DOI":"10.1016\/j.ijid.2013.03.019","article-title":"Diagnosis and treatment of tuberculous uveitis in a low endemic setting","volume":"17","author":"Vos","year":"2013","journal-title":"Int J Infect Dis"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00006982-200110000-00004","article-title":"PCR-positive tubercular retinal vasculitis: clinical characteristics and management","volume":"21","author":"Gupta","year":"2001","journal-title":"Retina"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajo.2021.03.040","article-title":"Classification criteria for tubercular uveitis","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"433.e1","DOI":"10.1016\/j.ajo.2011.02.006","article-title":"Quanti FERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation","volume":"152","author":"Gineys","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","article-title":"Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis","volume":"146","author":"Bansal","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001","article-title":"Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis","volume":"61","author":"Kee","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41433-019-0748-9","article-title":"Presumed ocular tuberculosis in the United Kingdom: a British ophthalmological surveillance unit (BOSU) study","volume":"34","author":"Shirley","year":"2020","journal-title":"Eye (Lond)"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:03:51Z","timestamp":1749319431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003558"}},"subtitle":["Prognostic Factors and Expanding the Role of Immunosuppressive Treatment in Retinal Vasculitis Associated With Positive QuantiFERON-TB Gold Test"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003558","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}